Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Wang

Showing results (451-460 of 603) with videos related to

Pageof 61
Sort By:
Cancer|September 3, 2011
A randomized phase 2 trial of a preparative regimen of bortezomib, high-dose melphalan, arsenic trioxide, and ascorbic acidManish Sharma, Hassan Khan, Peter F Thall, et al.
Neurosurgery|September 26, 2017
Patients with High Pelvic Tilt Achieve the Same Clinical Success as Those with Low Pelvic Tilt After Minimally Invasive Adult Deformity SurgeryJuan S Uribe, Jacob Januszewski, Michael Wang, et al.
Annals of Translational Medicine|May 1, 2018
Highlights from the First Annual Spinal Navigation, Emerging Technologies and Systems Integration MeetingDoniel Drazin, Peter Grunert, Roger Hartl, et al.
Blood|October 27, 2023
Two-year follow-up of lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma in TRANSCEND NHL 001Jeremy S Abramson, M Lia Palomba, Leo I Gordon, et al.
The New England Journal of Medicine|November 23, 2007
Lenalidomide plus dexamethasone for relapsed multiple myeloma in North AmericaDonna M Weber, Christine Chen, Ruben Niesvizky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2018
Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell LymphomasLan V Pham, Shengjian Huang, Hui Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2010
N1-Heterocyclic pyrimidinediones as non-nucleoside inhibitors of HIV-1 reverse transcriptaseMichael L Mitchell, Jong Chan Son, Ill Young Lee, et al.
Haematologica|October 12, 2019
Pre-treatment maximum standardized uptake value predicts outcome after frontline therapy in patients with advanced stage follicular lymphomaPaolo Strati, Mohamed Amin Ahmed, Nathan H Fowler, et al.
British Journal of Haematology|April 7, 2017
Characteristics, management, and outcomes of patients with follicular dendritic cell sarcomaPreetesh Jain, Sarah A Milgrom, Keyur P Patel, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Dominant Malignant Clones Leverage Lineage Restricted Epigenomic Programs to Drive Ependymoma DevelopmentAlisha Kardian, Hua Sun, Siri Ippagunta, et al.
Pageof 61

Showing results (451-460 of 603) with videos related to

Sort By:
Pageof 61
Cancer|September 3, 2011
A randomized phase 2 trial of a preparative regimen of bortezomib, high-dose melphalan, arsenic trioxide, and ascorbic acidManish Sharma, Hassan Khan, Peter F Thall, et al.
Neurosurgery|September 26, 2017
Patients with High Pelvic Tilt Achieve the Same Clinical Success as Those with Low Pelvic Tilt After Minimally Invasive Adult Deformity SurgeryJuan S Uribe, Jacob Januszewski, Michael Wang, et al.
Annals of Translational Medicine|May 1, 2018
Highlights from the First Annual Spinal Navigation, Emerging Technologies and Systems Integration MeetingDoniel Drazin, Peter Grunert, Roger Hartl, et al.
Blood|October 27, 2023
Two-year follow-up of lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma in TRANSCEND NHL 001Jeremy S Abramson, M Lia Palomba, Leo I Gordon, et al.
The New England Journal of Medicine|November 23, 2007
Lenalidomide plus dexamethasone for relapsed multiple myeloma in North AmericaDonna M Weber, Christine Chen, Ruben Niesvizky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2018
Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell LymphomasLan V Pham, Shengjian Huang, Hui Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2010
N1-Heterocyclic pyrimidinediones as non-nucleoside inhibitors of HIV-1 reverse transcriptaseMichael L Mitchell, Jong Chan Son, Ill Young Lee, et al.
Haematologica|October 12, 2019
Pre-treatment maximum standardized uptake value predicts outcome after frontline therapy in patients with advanced stage follicular lymphomaPaolo Strati, Mohamed Amin Ahmed, Nathan H Fowler, et al.
British Journal of Haematology|April 7, 2017
Characteristics, management, and outcomes of patients with follicular dendritic cell sarcomaPreetesh Jain, Sarah A Milgrom, Keyur P Patel, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Dominant Malignant Clones Leverage Lineage Restricted Epigenomic Programs to Drive Ependymoma DevelopmentAlisha Kardian, Hua Sun, Siri Ippagunta, et al.
Pageof 61